Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.8B | 4.0B | 3.9B | 3.8B |
Cost of revenue | 2.5B | 2.6B | 2.5B | 2.5B |
Gross profit | 1.3B | 1.4B | 1.4B | 1.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 508M | 453M | 522M | 509M |
Other operating expenses | — | — | — | — |
Operating income | 525M | 622M | 578M | 548M |
Non operating interest income | ||||
Income | 11M | 11M | 13M | 12M |
Expense | 165M | 171M | 170M | 163M |
Other income expense | -48M | 82M | -72M | 39M |
Pretax income | 323M | 544M | 349M | 436M |
Tax provision | 61M | 112M | 65M | 75M |
Net income | 249M | 437M | 285M | 363M |
Basic EPS | 1.4 | 2.4 | 1.6 | 2.0 |
Diluted EPS | 1.4 | 2.4 | 1.6 | 2.0 |
Basic average shares | 175.7M | 178.9M | 182.1M | 182.2M |
Diluted average shares | 177.4M | 180.8M | 184.2M | 184.3M |
EBITDA | 786M | 1.0B | 825M | 896M |
Net income from continuing op. | 249M | 437M | 285M | 363M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |